JAMA Health Forum · 2022 · 20 citations · 7 references
LawPsychiatryControlled Substance PolicyDrug LawSubstance Use DisordersCannabis RegulationControlled SubstancesDrugs Of AbuseFederal Controlled Substance LawSubstance UseCannabis CriminalizationCannabis Enforcement PolicyCannabis LabelingCannabis LicensingDrug Legalization PolicyPsychedelic Drug UseSubstance Use DecriminalizationSubstance Use Legalization
In 2020, Oregon became the first state in the US to decriminalize use of many illicit substances, including mushrooms containing psilocybin, and allow adults aged 21 years and older to take psilocybin under supervision in state-licensed service centers. Numerous states and municipalities have since proposed similar policies, 1 a process catalyzed by excitement about positive clinical trials of psychedelics for psychiatric conditions 2,3 and the entry of commercial interests into psychedelic drug development.
7
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder
Alan K. Davis, Frederick S. Barrett, Darrick G. May et al. · JAMA Psychiatry · 2020 · 1.3K citations · Full text
Acute Illness Associated With Cannabis Use, by Route of Exposure
Andrew A. Monte, Shelby K. Shelton, Eleanor Mills et al. · Annals of Internal Medicine · 2019 · 171 citations · Full text
James Rucker, Lindsey Marwood, Riikka-Liisa Johanna Ajantaival et al. · Journal of Psychopharmacology · 2022 · 101 citations · Full text
Medicine, Pharmacology, Psychiatry +13